Blocking the TLR4/NF-κB Cascade Reverses the Promotion Effect of Overexpression of REB2 on Liver Injury and Inflammation in NAFLD Rats. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.